Department of Internal Medicine, Hypertension and Vascular Research Division, Henry Ford Hospital, 2799 West Grand Blvd., Detroit, MI 48202, USA.
Am J Physiol Renal Physiol. 2010 Apr;298(4):F885-91. doi: 10.1152/ajprenal.00543.2009. Epub 2010 Jan 6.
We showed that luminal flow increases net superoxide (O(2)(-)) production via NADPH oxidase in thick ascending limbs. Protein kinase C (PKC) activates NADPH oxidase activity in phagocytes, cardiomyocytes, aortic endothelial cells, vascular smooth muscle cells, and renal mesangial cells. However, the flow-activated pathway that induces NADPH oxidase activity in thick ascending limbs is unclear. We hypothesized that PKC mediates flow-stimulated net O(2)(-) production by thick ascending limbs. Initiation of flow (20 nl/min) increased net O(2)(-) production from 4 +/- 1 to 61 +/- 12 AU/s (P < 0.007; n = 5). The NADPH oxidase inhibitor apocynin completely blocked the flow-induced increase in net O(2)(-) production (2 +/- 1 vs. 1 +/- 1 AU/s; P > 0.05; n = 5). Flow-stimulated O(2)(-) was also blocked in p47(phox)-deficient mice. We measured flow-stimulated PKC activity with a fluorescence resonance energy transfer (FRET)-based membrane-targeted PKC activity reporter and found that the FRET ratio increased from 0.87 +/- 0.02 to 0.96 +/- 0.04 AU (P < 0.05; n = 6). In the absence of flow, the PKC activator phorbol 12-myristate 13-acetate (200 nM) enhanced net O(2)(-) production from 5 +/- 2 to 92 +/- 6 AU/s (P < 0.001; n = 6). The PKC-alpha- and betaI-selective inhibitor Gö 6976 (100 nM) decreased flow-stimulated net O(2)(-) production from 54 +/- 15 to 2 +/- 1 AU/s (P < 0.04; n = 5). Flow-induced net O(2)(-) production was inhibited in thick ascending limbs transduced with dominant-negative (dn)PKC-alpha but not dnPKCbetaI or LacZ (Delta = 11 +/- 3 AU/s for dnPKCalpha, 55 +/- 7 AU/s for dnPKCbetaI, and 63 +/- 7 AU/s for LacZ; P < 0.001; n = 6). We concluded that flow stimulates net O(2)(-) production in thick ascending limbs via PKC-alpha-mediated activation of NADPH oxidase.
我们表明,腔内流动通过 NADPH 氧化酶增加厚升支中的净超氧化物(O(2)(-))产生。蛋白激酶 C(PKC)激活吞噬细胞、心肌细胞、主动脉内皮细胞、血管平滑肌细胞和肾系膜细胞中的 NADPH 氧化酶活性。然而,诱导厚升支中 NADPH 氧化酶活性的流动激活途径尚不清楚。我们假设 PKC 介导厚升支中流动刺激的净 O(2)(-)产生。起始流动(20 nl/min)将净 O(2)(-)产生从 4 +/- 1 增加到 61 +/- 12 AU/s(P < 0.007;n = 5)。NADPH 氧化酶抑制剂 apocynin 完全阻断了流动诱导的净 O(2)(-)产生增加(2 +/- 1 对 1 +/- 1 AU/s;P > 0.05;n = 5)。在 p47(phox)-缺陷型小鼠中,也阻断了流动刺激的 O(2)(-)。我们使用荧光共振能量转移(FRET)基于膜靶向的 PKC 活性报告器测量了流动刺激的 PKC 活性,并发现 FRET 比从 0.87 +/- 0.02 增加到 0.96 +/- 0.04 AU(P < 0.05;n = 6)。在没有流动的情况下,PKC 激活剂佛波醇 12-肉豆蔻酸 13-醋酸盐(200 nM)将净 O(2)(-)产生从 5 +/- 2 增加到 92 +/- 6 AU/s(P < 0.001;n = 6)。PKC-alpha 和 betaI 选择性抑制剂 Gö 6976(100 nM)将流动刺激的净 O(2)(-)产生从 54 +/- 15 减少到 2 +/- 1 AU/s(P < 0.04;n = 5)。在转导有显性负性(dn)PKC-alpha 的厚升支中,流动诱导的净 O(2)(-)产生受到抑制,但 dnPKCbetaI 或 LacZ 则没有(dnPKCalpha 为 11 +/- 3 AU/s,dnPKCbetaI 为 55 +/- 7 AU/s,LacZ 为 63 +/- 7 AU/s;P < 0.001;n = 6)。我们得出结论,PKC-alpha 介导的 NADPH 氧化酶激活通过流动刺激厚升支中的净 O(2)(-)产生。